Long-Term Survival of Patients With Left Ventricular Noncompaction.


Journal

Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524

Informations de publication

Date de publication:
19 01 2021
Historique:
pubmed: 15 1 2021
medline: 15 10 2021
entrez: 14 1 2021
Statut: ppublish

Résumé

Background The prognosis of left ventricular noncompaction (LVNC) remains elusive despite its recognition as a clinical entity for >30 years. We sought to identify clinical and imaging characteristics and risk factors for mortality in patients with LVNC. Methods and Results 339 adults with LVNC seen between 2000 and 2016 were identified. LVNC was defined as end-systolic noncompacted to compacted myocardial ratio >2 (Jenni criteria) and end-diastolic trough of trabeculation-to-epicardium (X):peak of trabeculation-to-epicardium (Y) ratio <0.5 (Chin criteria) by echocardiography; and end-diastolic noncompacted:compacted ratio >2.3 (Petersen criteria) by magnetic resonance imaging. Median age was 47.4 years, and 46% of patients were female. Left ventricular ejection fraction <50% was present in 57% of patients and isolated apical noncompaction in 48%. During a median follow-up of 6.3 years, 59 patients died. On multivariable Cox regression analysis, age (hazard ratio [HR] 1.04; 95% CI, 1.02-1.06), left ventricular ejection fraction <50% (HR, 2.37; 95% CI, 1.17-4.80), and noncompaction extending from the apex to the mid or basal segments (HR, 2.11; 95% CI, 1.21-3.68) were associated with all-cause mortality. Compared with the expected survival for age- and sex-matched US population, patients with LVNC had reduced overall survival (

Identifiants

pubmed: 33441029
doi: 10.1161/JAHA.119.015563
pmc: PMC7955291
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e015563

Subventions

Organisme : NHLBI NIH HHS
ID : K01 HL135288
Pays : United States

Commentaires et corrections

Type : CommentIn

Références

J Am Coll Cardiol. 2014 Oct 28;64(17):1840-50
pubmed: 25443708
Int J Cardiol. 2013 May 25;165(3):463-7
pubmed: 21944384
Heart Rhythm. 2011 Aug;8(8):1308-39
pubmed: 21787999
JAMA. 2004 Jul 21;292(3):344-50
pubmed: 15265849
J Am Coll Cardiol. 2018 Feb 20;71(7):723-726
pubmed: 29447732
J Am Coll Cardiol. 2019 Apr 9;73(13):1601-1611
pubmed: 30947911
J Am Coll Cardiol. 2018 Feb 20;71(7):711-722
pubmed: 29447731
Heart. 2001 Dec;86(6):666-71
pubmed: 11711464
Cardiovasc Intervent Radiol. 1986;9(3):127-31
pubmed: 3089618
Can J Cardiol. 2017 Jun;33(6):701-704
pubmed: 28545618
Eur Heart J. 2017 Dec 7;38(46):3449-3460
pubmed: 29029073
JACC Cardiovasc Imaging. 2015 Aug;8(8):934-46
pubmed: 26189121
Anat Rec. 2000 Apr 1;258(4):319-37
pubmed: 10737851
Circulation. 2006 Apr 11;113(14):1807-16
pubmed: 16567565
J Am Coll Cardiol. 2014 Nov 11;64(19):1971-80
pubmed: 25440091
J Am Coll Cardiol. 2005 Jul 5;46(1):101-5
pubmed: 15992642
Eur J Heart Fail. 2011 Feb;13(2):177-85
pubmed: 21193437
N Engl J Med. 2017 Jul 6;377(1):41-51
pubmed: 28679089
ScientificWorldJournal. 2006 Apr 25;6:1862-80
pubmed: 17205193
Am J Cardiol. 2012 Jan 15;109(2):276-81
pubmed: 22036106
Int J Cardiol. 2012 Jul 26;158(3):394-9
pubmed: 21345500
JACC Heart Fail. 2017 Nov;5(11):763-771
pubmed: 29032140
Int J Cardiol. 2013 Sep 30;168(2):1658-60
pubmed: 23582434
J Am Heart Assoc. 2021 Jan 19;10(2):e015563
pubmed: 33441029
Eur Heart J. 2008 Jan;29(2):270-6
pubmed: 17916581
Nat Commun. 2017 Jul 20;8(1):87
pubmed: 28729659
Circ Cardiovasc Imaging. 2020 Jan;13(1):e009712
pubmed: 31959004
Circulation. 2013 Sep 24;128(13):1433-41
pubmed: 23946264
Can J Cardiol. 2017 Jun;33(6):747-757
pubmed: 28395867
J Am Coll Cardiol. 2000 Aug;36(2):493-500
pubmed: 10933363
Circulation. 1990 Aug;82(2):507-13
pubmed: 2372897
Circ Cardiovasc Imaging. 2017 Sep;10(9):
pubmed: 28899950
JACC Cardiovasc Imaging. 2019 Nov;12(11 Pt 1):2141-2151
pubmed: 30878415
JAMA Cardiol. 2018 Nov 1;3(11):1033-1034
pubmed: 30140926
Eur Heart J. 2011 Jun;32(12):1446-56
pubmed: 21285074
J Card Fail. 2006 Dec;12(9):726-33
pubmed: 17174235
JACC Cardiovasc Imaging. 2013 Sep;6(9):931-40
pubmed: 23769489
Heart. 2006 Jun;92(6):785-91
pubmed: 16216855
Lancet. 2015 Aug 22;386(9995):813-25
pubmed: 25865865
Heart. 2007 Jan;93(1):65-71
pubmed: 16644854
Circulation. 2014 Aug 5;130(6):475-83
pubmed: 25006201
Eur Heart J. 2010 May;31(9):1098-104
pubmed: 20089517
J Am Coll Cardiol. 2016 Nov 15;68(20):2166-2181
pubmed: 27855806
Radiology. 2015 Dec;277(3):707-15
pubmed: 26069924
N Engl J Med. 2000 Apr 13;342(15):1077-84
pubmed: 10760308
N Engl J Med. 2006 Jul 20;355(3):251-9
pubmed: 16855265
Heart. 2013 Mar;99(6):401-8
pubmed: 23393084

Auteurs

Vaibhav R Vaidya (VR)

Department of Cardiovascular Diseases Mayo Clinic Rochester MN.

Melissa Lyle (M)

Department of Cardiovascular Diseases Mayo Clinic Rochester MN.

William R Miranda (WR)

Department of Cardiovascular Diseases Mayo Clinic Rochester MN.

Medhat Farwati (M)

Department of Cardiovascular Diseases Mayo Clinic Rochester MN.

Ameesh Isath (A)

Department of Cardiovascular Diseases Mayo Clinic Rochester MN.

Sri Harsha Patlolla (SH)

Department of Cardiovascular Diseases Mayo Clinic Rochester MN.

David O Hodge (DO)

Department of Cardiovascular Diseases Mayo Clinic Jacksonville FL.

Samuel J Asirvatham (SJ)

Department of Cardiovascular Diseases Mayo Clinic Rochester MN.
Department of Pediatrics and Adolescent Medicine Mayo Clinic Rochester MN.

Suraj Kapa (S)

Department of Cardiovascular Diseases Mayo Clinic Rochester MN.

Abhishek J Deshmukh (AJ)

Department of Cardiovascular Diseases Mayo Clinic Rochester MN.

Thomas A Foley (TA)

Department of Radiology Mayo Clinic Rochester MN.

Hector I Michelena (HI)

Department of Cardiovascular Diseases Mayo Clinic Rochester MN.

Heidi M Connolly (HM)

Department of Cardiovascular Diseases Mayo Clinic Rochester MN.

Rowlens M Melduni (RM)

Department of Cardiovascular Diseases Mayo Clinic Rochester MN.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH